Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|March 9, 2021
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factorsJoana M Rodrigues, Anna Nikkarinen, Peter Hollander, et al.
Blood|October 9, 2014
Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphomaArne Kolstad, Shraddha Kumari, Mateusz Walczak, et al.
Haematologica|December 15, 2022
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factorsAnna Sandström Gerdtsson, Joana de Matos Rodrigues, Christian Winther Eskelund, et al.
European Journal of Haematology|August 2, 2003
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplantNiels S Andersen, Lone Pedersen, Erkki Elonen, et al.
British Journal of Haematology|January 19, 2011
High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II studyMarianne B Eide, Grete F Lauritzsen, Gunnar Kvalheim, et al.
Oncoimmunology|July 29, 2016
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLANadia Mensali, Fan Ying, Vincent Oei Yi Sheng, et al.
NPJ Vaccines|August 22, 2023
A systematic safety pipeline for selection of T-cell receptors to enter clinical useZsofia Foldvari, Cathrine Knetter, Weiwen Yang, et al.
Plos One|April 29, 2022
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitroMarion M Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares, et al.
Blood|November 8, 2011
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatmentOlav Erich Yri, Dag Torfoss, Olav Hungnes, et al.
Leukemia & Lymphoma|June 1, 2023
Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 scoreRuth Salim, Simon Husby, Christian Winther Eskelund, et al.
Pageof 10